# The Efficacy and Safety of Low-Level Tragus Stimulation on Heart Rate Variability, Neutrophil-Lymphocyte Ratio, and Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction (TESLA-STEMI)

Study · id `cardio:ct-nct06537583` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06537583](<https://clinicaltrials.gov/study/NCT06537583>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06537583

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT06537583. Randomized; single masking; primary purpose treatment. Start 2024-01-01 (actual); primary completion 2024-08-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT06537583, source copy `cardio:ctgov-nct06537583-2024-08-05`, retrieved 2026-10-26)
- Started: 2024-01-01 (actual) (ClinicalTrials.gov record NCT06537583, source copy `cardio:ctgov-nct06537583-2024-08-05`, retrieved 2026-10-26)
- Primary completion: 2024-08-31 (anticipated) (ClinicalTrials.gov record NCT06537583, source copy `cardio:ctgov-nct06537583-2024-08-05`, retrieved 2026-10-26)
- Completion: 2024-09-30 (anticipated) (ClinicalTrials.gov record NCT06537583, source copy `cardio:ctgov-nct06537583-2024-08-05`, retrieved 2026-10-26)
- Countries: Indonesia (ClinicalTrials.gov record NCT06537583, source copy `cardio:ctgov-nct06537583-2024-08-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06537583-2024-08-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Efficacy and Safety of Low-Level Tragus Stimulation on Heart Rate Variability, Neutrophil-Lymphocyte Ratio, and Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction (TESLA-STEMI)
- Acronym: TESLA-STEMI
- Condition: ST Elevation Myocardial Infarction
- Intervention (Device): Parasym Neuromodulation Device (Treatment Group)
- Intervention (Device): Parasym Neuromodulation Device (Sham Group)
- Lead sponsor: Universitas Diponegoro
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)

## Provenance

Content hash: 164a41f2125b10800b15cbb4ba8087b906fe0dd69c216c61e9b73baf17a072dd
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
